Close Menu

NEW YORK (GenomeWeb) – While cancer stem cells (CSCs) — subpopulations of cells within a tumor that are capable of driving the disease — have become a promising subject of research, their scarcity and the complexity associated with their isolation has made their use in drug screening difficult.

But a new method developed by a team from the University of Florida, Gainesville promises to overcome this hurdle, enabling the delivery of small-molecule drugs to individual islands of rare patient-derived cancer cells on a miniaturized microarray platform.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Kaiser Health News reports San Francisco and Alameda counties in California are no longer using Verily Life Sciences' COVID-19 testing program.

The New York Times reports that developers in New York City are increasingly interested in life science spaces.

A UK study has found that antibodies against SARS-CoV-2 may decline over time, Reuters reports.

In PNAS this week: genetic and epigenetic variation in individuals with diabetic kidney disease, spontaneous genetic alterations in Saccharomyces cerevisiae, and more.

Sponsored by

Selective breeding represents an efficient approach to increase production of aquaculture species by means of improving traits, such as rapid growth, product quality, and disease resistance.